India, Jan. 21 -- The Indian healthtech sector is in its transition phase, with VCs rethinking their bets. In the Covid era, the likes of PharmEasy, Practo, and 1mg (now Tata 1mg) soaked up capital, driven by a surge in digital adoption, telemedicine, and epharmacy. But this has now changed, with companies returning to a customer-first approach while integrating technology across the healthcare ecosystem.

This shift is also visible in the numbers.

According to Inc42's 'Annual Indian Startup Trends Report, 2025', the market for healthtech is projected to grow at 39% CAGR from 2025 to breach the $37 Bn+ mark by 2030. Yet, healthtech is no longer the investor darling that it used to be.

The number of deals declined from 78 in 2024 to 54 d...